Zobrazeno 1 - 10
of 620
pro vyhledávání: '"Darlison, L"'
Autor:
Gibson AEJ; Putnam Associates, 22-24 Torrington Place, Fitzrovia, London, WC1E 7HJ, UK. adam.gibson@putassoc.com., Ahmed W; Putnam Associates, 22-24 Torrington Place, Fitzrovia, London, WC1E 7HJ, UK., Longworth L; Putnam Associates, 22-24 Torrington Place, Fitzrovia, London, WC1E 7HJ, UK., Bennett B; Bristol Myers Squibb (formerly), Sanderson Rd, Denham, Uxbridge, UB8 1DH, UK., Daumont M; Bristol Myers Squibb (formerly), Avenue de Finlande 8, Building F - 1st Floor, 1420, Braine-l'Alleud, Belgium., Darlison L; Mesothelioma UK, 235 Loughborough Road, Mountsorrel, Loughborough, Leicestershire, LE12 7AS, UK.
Publikováno v:
The patient [Patient] 2024 Sep; Vol. 17 (5), pp. 551-563. Date of Electronic Publication: 2024 Apr 15.
Autor:
Zhang M; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK.; Novogene Corporation, Beijing, China., Bzura A; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Baitei EY; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK.; Center for Genomic Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Zhou Z; Department of Informatics, University of Leicester, Leicester, UK., Spicer JB; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Poile C; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Rogel J; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Branson A; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK., King A; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK., Barber S; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK., Kamata T; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Dzialo J; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Harber J; Harry Perkins Institute of Medical Research and The University of Western Australia Centre for Cancer Research, Perth, WA, Australia., Greystoke A; Northern Centre for Cancer Care, Newcastle, UK., Nusrat N; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Faulkner D; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Sun Q; Novogene Corporation, Beijing, China., Nolan L; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hahne JC; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Scotland M; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK., Walter H; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK.; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK., Darlison L; Mesothelioma, Leicester, UK., Morgan B; Department of Radiology, University Hospitals of Leicester NHS Trust, Leicester, UK., Bajaj A; Department of Radiology, University Hospitals of Leicester NHS Trust, Leicester, UK., Brookes C; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK., Hollox EJ; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK., Lubawska D; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK., Jama M; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Griffiths G; University of Southampton Clinical Trials Unit, Southampton, UK., Nakas A; Department of Cardiothoracic Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK., Kutywayo K; Department of Cardiothoracic Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK., Luo JL; Bioinformatics and Statistics Analysis Hub, University of Leicester, Leicester, UK., Klampatsa A; Institute of Cancer Research, Sutton, UK., Cooper A; Department of Respiratory Sciences, University of Leicester, Leicester, UK., Halder K; Department of Respiratory Sciences, University of Leicester, Leicester, UK., Wells-Jordan P; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Zhou H; Department of Informatics, University of Leicester, Leicester, UK., Dudbridge F; Department of Health Sciences, University of Leicester, Leicester, UK., Thomas A; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK.; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK., Richards CJ; Department of Pathology, University Hospitals of Leicester NHS Trust, Leicester, UK., Pritchard C; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK., Yang H; Department of Informatics, University of Leicester, Leicester, UK., Barer M; Department of Respiratory Sciences, University of Leicester, Leicester, UK., Fennell DA; National Institute for Health Research Biomedical Research Centre & Cancer Research UK Experimental Cancer Medicine Centre, University of Leicester, Leicester, UK. df132@leicester.ac.uk.; Department of Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK. df132@leicester.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 21; Vol. 15 (1), pp. 7187. Date of Electronic Publication: 2024 Aug 21.
Autor:
Lond B; Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom. Electronic address: blond@brookes.ac.uk., Dodd C; Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom., Davey Z; Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom., Darlison L; University Hospitals of Leicester, The Glenfield Hospital, Leicester, United Kingdom., McPhelim J; University Hospital Hairmyres, NHS Lanarkshire, East Kilbride, United Kingdom., Rawlinson J; Lung Cancer Patient Advisory Group, European Lung Foundation, Sheffield, United Kingdom; British Thoracic Oncology Group Steering Committee, Leicester, United Kingdom., Williamson I; Division of Psychology, De Montfort University, Leicester, United Kingdom., Merriman C; Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom; Oxford University Hospital Foundation Trust, Oxford, United Kingdom., Waddington F; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom., Bagnallainslie D; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom., Rajendran B; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom., Usman J; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom., Henshall C; Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom; Oxford Health NHS Foundation Trust, The Warneford Hospital, Oxford, United Kingdom.
Publikováno v:
European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2024 Jun; Vol. 70, pp. 102564. Date of Electronic Publication: 2024 Mar 19.
Autor:
Blyth KG; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Queen Elizabeth University Hospital, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow, UK. Electronic address: kevin.blyth@glasgow.ac.uk., Adusumilli PS; Department of Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Cellular Therapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Astoul P; Thoracic Oncology Department, Hôpital NORD, Aix-Marseille University, Marseille, France., Darlison L; Mesothelioma UK, Leicester, UK., Lee YCG; University of Western Australia, Perth, WA, Australia; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Marciniak SJ; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK., Maskell N; Academic Respiratory Unit, University of Bristol, Bristol, UK; Department of Respiratory Medicine, Southmead Hospital, Bristol, UK., Panou V; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark; Odense Respiratory Research Unit, University of Southern Denmark, Odense, Denmark; Department of Respiratory Diseases, Aalborg University Hospital, Aalborg, Denmark., Peikert T; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA., Rahman NM; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Zauderer MG; Cellular Therapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sterman D; New York University School of Medicine, New York, NY, USA., Fennell DA; University of Leicester, Leicester, UK; University Hospitals of Leicester NHS Trust, Leicester, UK.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Jun; Vol. 12 (6), pp. 476-483. Date of Electronic Publication: 2024 May 10.
Autor:
Fennell D; Mesothelioma Research Programme, Department of Genetics and Genome Biology, University of Leicester & University Hospitals of Leicester NHS Trust, Leicester, UK., Griffiths D; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK dpg1e20@soton.ac.uk., Eminton Z; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Morgan-Fox A; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Hill K; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Ewings S; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Stuart C; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Johnson L; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Mallard K; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Nye M; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK., Darlison L; Mesothelioma Research Programme, University Hospitals of Leicester NHS Trust, Leicester, UK., Dulloo S; Department of Genetics and Genome Biology, University Hospitals of Leicester NHS Trust, Leicester, UK., Cave J; Department of Oncology, Wessex NET group ENETS Centre of Excellence, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Luo JL; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Taylor P; Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Spicer J; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Poile C; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Bzura A; Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Griffiths G; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
Publikováno v:
BMJ open [BMJ Open] 2023 Nov 22; Vol. 13 (11), pp. e073120. Date of Electronic Publication: 2023 Nov 22.
Autor:
Fennell, D.A., Ewings, S., Ottensmeier, C., Califano, R., Hanna, G.G., Hill, K., Danson, S., Steele, N., Nye, M., Johnson, L., Lord, J., Middleton, C., Szlosarek, P., Chan, S., Gaba, A., Darlison, L., Wells-Jordan, P., Richards, C., Poile, C., Lester, J.F., Griffiths, G., Price, G., Shaw, P., Cave, J., Naik, J., Ford, A., Geldhart, T., Dancey, G., Papadatos, D., Polychronis, A., Jankowska, P., Scott, A., Gardiner, J., Cominos, M., Campbell, L., MacGregor, C., Mullholand, L., Chitnis, M., Dougherty, G.
Background\ud \ud No phase 3 trial has yet shown improved survival for patients with pleural or peritoneal malignant mesothelioma who have progressed following platinum-based chemotherapy. The aim of this study was to assess the efficacy and safety o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::2e2f3b751568e16874b769283a50cfa3
https://eprints.whiterose.ac.uk/179870/6/1-s2.0-S147020452100471X-main.pdf
https://eprints.whiterose.ac.uk/179870/6/1-s2.0-S147020452100471X-main.pdf
Background:\ud \ud People with mesothelioma and their families have palliative care needs throughout the relatively short trajectory of their illness.\ud \ud \ud \ud Aim:\ud \ud To describe the palliative care needs and experiences of people with mes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1f5fc79b94ed6de9821d8a7fb41c2327
https://eprints.whiterose.ac.uk/172941/1/02692163211007379.pdf
https://eprints.whiterose.ac.uk/172941/1/02692163211007379.pdf
Autor:
Hargreaves S; Mesothelioma UK Research Centre, Health Sciences School, University of Sheffield, Sheffield, South Yorkshire, UK., Gardiner C; Mesothelioma UK Research Centre, Health Sciences School, University of Sheffield, Sheffield, South Yorkshire, UK., Tod A; Mesothelioma UK Research Centre, Health Sciences School, University of Sheffield, Sheffield, South Yorkshire, UK., Darlison L; University Hospitals of Leicester, Leicester, Leicestershire, UK.
Publikováno v:
British journal of community nursing [Br J Community Nurs] 2023 May 02; Vol. 28 (5), pp. 248-252.
Autor:
Harden SV; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. susan.harden@nhs.net., Darlison L; University Hospitals of Leicester, Leicester, UK., Beckett P; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK., Bibby AC; Academic Respiratory Unit, Bristol University, Bristol, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Nov; Vol. 123 (11), pp. 1588-1589. Date of Electronic Publication: 2020 Sep 22.
Publikováno v:
BMJ Open Respiratory Research
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
ObjectivesMalignant mesothelioma is an aggressive malignancy of mesothelial surfaces, most commonly those of the pleura. The aim of this study was to understand, using a national questionnaire, the gendered care experiences of patients with malignant